BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 12860795)

  • 1. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
    Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M;
    Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial.
    Optic Neuritis Study Group
    Neurology; 1997 Nov; 49(5):1404-13. PubMed ID: 9371930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
    Marques IB; Matias F; Silva ED; Cunha L; Sousa L
    J Clin Neurosci; 2014 Apr; 21(4):583-6. PubMed ID: 24231563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.
    Optic Neuritis Study Group
    Arch Neurol; 2008 Jun; 65(6):727-32. PubMed ID: 18541792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis.
    Optic Neuritis Study Group
    Arch Neurol; 2004 Oct; 61(10):1538-41. PubMed ID: 15477507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
    Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
    Swanton JK; Fernando KT; Dalton CM; Miszkiel KA; Altmann DR; Plant GT; Thompson AJ; Miller DH
    Mult Scler; 2010 Feb; 16(2):156-65. PubMed ID: 20086028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic neuritis.
    Clark D; Kebede W; Eggenberger E
    Neurol Clin; 2010 Aug; 28(3):573-80. PubMed ID: 20637989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic Neuritis in Korean Children: Low Risk of Subsequent Multiple Sclerosis.
    Kim YM; Kim HY; Cho MJ; Kwak MJ; Park KH; Yeon GM; Lee Y; Nam SO
    Pediatr Neurol; 2015 Sep; 53(3):221-5. PubMed ID: 26183177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A risk of developing multiple sclerosis following an outbreak of optic neuritis during a mean follow-up of 4.5 years].
    Deyá E; Sevilla T; Coret F
    Neurologia; 1998 Oct; 13(8):377-81. PubMed ID: 9859669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.
    Lai C; Chang Q; Tian G; Wang J; Yin H; Liu W
    PLoS One; 2015; 10(10):e0141005. PubMed ID: 26485719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis.
    CHAMPS Study Group
    Am J Ophthalmol; 2001 Oct; 132(4):463-71. PubMed ID: 11589865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcome of childhood optic neuritis at Queen Sirikit National Institute of Child Health.
    Sri-udomkajorn S; Pongwatcharaporn K
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S189-94. PubMed ID: 22043775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
    Cramer SP; Modvig S; Simonsen HJ; Frederiksen JL; Larsson HB
    Brain; 2015 Sep; 138(Pt 9):2571-83. PubMed ID: 26187333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood optic neuritis clinical features and outcome.
    Absoud M; Cummins C; Desai N; Gika A; McSweeney N; Munot P; Hemingway C; Lim M; Nischal KK; Wassmer E
    Arch Dis Child; 2011 Sep; 96(9):860-2. PubMed ID: 20554767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term prospective study of optic neuritis: evaluation of risk factors.
    Sandberg-Wollheim M; Bynke H; Cronqvist S; Holtås S; Platz P; Ryder LP
    Ann Neurol; 1990 Apr; 27(4):386-93. PubMed ID: 2353793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study].
    Río J; Nos C; Rovira A; Tintoré M; Codina A; Montalbán X
    Med Clin (Barc); 1997 Sep; 109(10):370-2. PubMed ID: 9379718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute demyelinating optic neuritis.
    Balcer LJ; Galetta SL
    Semin Ophthalmol; 2002 Mar; 17(1):4-10. PubMed ID: 15513449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.